Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | Hematology in focus: MGUS with clinical significance

Joan Bladé • 14 Jun 2019
EHA 2019
Multiple Myeloma

Joan Bladé, MD, Hospital Clinic, Barcelona, Spain, discusses monoclonal gammopathy of unknown significance (MGUS), and the diseases associated with the condition at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Joan Bladé

2:36
Looking forward to ISA 2022
Joan Bladé • 12 May 2022
1:02
How the amyloidosis treatment landscape has transformed in recent years
Joan Bladé • 12 May 2022
3:26
Managing and treating renal impairment in multiple myeloma
Joan Bladé • 12 May 2022
3:05
Amyloidosis classification and epidemiology
Joan Bladé • 4 Sep 2020

Related Videos

1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals